Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis.
Gregory GE, Islim AI, Hannan CJ, Jones AP, Hammerbeck-Ward C, Rutherford SA, Freeman SR, Lloyd S, Kalamarides M, Smith MJ, Couper K, McBain CA, Jenkinson MD, Brough D, King AT, Evans DG, Pathmanaban ON. Gregory GE, et al. Among authors: jones ap. Neurooncol Adv. 2023 Jun 3;5(Suppl 1):i94-i104. doi: 10.1093/noajnl/vdac127. eCollection 2023 May. Neurooncol Adv. 2023. PMID: 37287576 Free PMC article.
Survival trends in elderly myeloma patients.
Jones A, Bowcock S, Rachet B. Jones A, et al. Eur J Haematol. 2021 Jan;106(1):126-131. doi: 10.1111/ejh.13530. Epub 2020 Oct 29. Eur J Haematol. 2021. PMID: 33037667
Diastereoselective β-hydroxy vinylsulfone isomerizations.
O'Neil GW, Clark TD, Jones AP, Wallace C, Carnahan DM, Crockett H. O'Neil GW, et al. Among authors: jones ap. Org Biomol Chem. 2025 Jan 15. doi: 10.1039/d4ob01781a. Online ahead of print. Org Biomol Chem. 2025. PMID: 39812345
Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma Model.
Lu S, Yin Z, Wu L, Sun Y, Chen J, Wu LMN, Oblinger JL, Blake DC, Landegger LD, Seist R, Ho W, Xiu B, Jones AP, Muzikansky A, Stankovic KM, Plotkin SR, Chang LS, Xu L. Lu S, et al. Among authors: jones ap. bioRxiv [Preprint]. 2024 Dec 29:2024.12.29.630658. doi: 10.1101/2024.12.29.630658. bioRxiv. 2024. PMID: 39763968 Free PMC article. Preprint.
Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage Plasmodium yoelii non-lethal infection.
Dookie RS, Villegas-Mendez A, Cheeseman A, Jones AP, Barroso R, Barrett JR, Draper SJ, Janse CJ, Grogan JL, MacDonald AS, Couper KN. Dookie RS, et al. Among authors: jones ap. Infect Immun. 2024 Nov 12;92(11):e0034524. doi: 10.1128/iai.00345-24. Epub 2024 Sep 26. Infect Immun. 2024. PMID: 39324794 Free article.
The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trial.
Bruce G, Rosala-Hallas A, Jones AP, Turner C, Dalton N, Hilger E, Baron S, Beattie P, Browne F, Brown SJ, Gach JE, Hearn R, Esdaile B, Cork MJ, Howard E, Greenblatt D, August S, Lovgren ML, Ashoor F, McPherson T, O'Kane D, Ravenscroft J, Shaw L, Spowart C, Thomas BR, Sach T, Wan M, Irvine AD, Sinha MD, Flohr C. Bruce G, et al. Among authors: jones ap. Br J Dermatol. 2024 Oct 17;191(5):851-852. doi: 10.1093/bjd/ljae276. Br J Dermatol. 2024. PMID: 39009427 Free article. No abstract available.
338 results